From medieval remedy to modern research

Tanacetum vulgare, commonly known as tansy, was a staple in medieval European medicine for treating intestinal parasites. Historical records from the 16th century, such as John Gerard’s Herball, document its use against worms. However, by the 19th century, tansy fell out of favor due to toxicity concerns related to its thujone content.

Recent studies published in the Journal of Ethnopharmacology (2021) have revived interest in tansy, particularly thujone-free extracts. Dr. Emily Carter, a parasitologist at Johns Hopkins University, notes: Our lab tests show these modified tansy compounds maintain antiparasitic activity while reducing neurotoxic risks by 80%.

Comparing efficacy against common parasites

A 2022 comparative study in Parasitology Research found tansy extracts demonstrated:

• 75% efficacy against giardia versus 82% for metronidazole
• 68% clearance of pinworms compared to 91% with pyrantel pamoate

Functional medicine practitioner Dr. Mark Williams explains: When drug resistance appears, we’re seeing tansy protocols work where pharmaceuticals fail, particularly in recurring giardia cases.

Risk-benefit analysis

Factor	Tansy Extract	Pharmaceuticals
Efficacy	Moderate-high	High
Resistance	Low incidence	Increasing
Safety	Controlled use only	Generally safe

Clinical contraindications

Key restrictions include:

• Absolute contraindication in pregnancy (may stimulate uterine contractions)
• Not recommended for children under 12
• Maximum 14-day treatment cycles

Veterinary case study

A 2023 trial at Colorado State University Veterinary School used supervised tansy protocols in livestock with drug-resistant nematodes. Dr. Sarah Chen reported: We achieved 62% parasite reduction with no neurological side effects using our standardized extract.